Rhenman & Partners Asset Management AB
Q2 2026 13F filing
Updated 28 days ago99 disclosed positions worth $1.1B
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | U UNH UNITED HEALTH GROUP INC | $38.9M | 93.6K | 3.67% | — |
| 2 | C CVS CVS HEALTH CORP | $28.9M | 279.4K | 2.73% | — |
| 3 | A AZN ASTRAZENECA PLC | $28.5M | 151.5K | 2.69% | — |
| 4 | M MRK MERCK & CO INC | $27.4M | 213.5K | 2.59% | — |
| 5 | L LLY LILLY ELI & CO | $26.8M | 22.3K | 2.53% | — |
| 6 | A ABBV ABBVIE INC | $24.4M | 96.8K | 2.30% | — |
| 7 | A ALHC ALIGNMENT HEALTHCARE INC | $23.7M | 997.1K | 2.24% | — |
| 8 | E EW EDWARDS LIFESCIENCES CORP | $23.5M | 260.0K | 2.22% | — |
| 9 | G GILD GILEAD SCIENCES INC | $22.5M | 178.3K | 2.13% | — |
| 10 | J JAZZ JAZZ PHARMACEUTICALS PLC | $21.1M | 87.4K | 1.99% | — |
| 11 | B BIIB BIOGEN INC | $20.5M | 94.8K | 1.93% | — |
| 12 | S SYK STRYKER CORPORATION | $20.5M | 65.0K | 1.93% | — |
| 13 | B BSX BOSTON SCIENTIFIC CORP | $19.2M | 450.5K | 1.81% | — |
| 14 | J JNJ JOHNSON & JOHNSON | $18.4M | 72.5K | 1.74% | — |
| 15 | G GH GUARDANT HEALTH INC | $17.3M | 115.0K | 1.63% | — |
| 16 | R REGN REGENERON PHARMACEUTICALS | $17.1M | 27.4K | 1.61% | — |
| 17 | G GKOS GLAUKOS CORP | $16.6M | 119.0K | 1.57% | — |
| 18 | B BMRN BIOMARIN PHARMACEUTICAL INC | $16.6M | 290.5K | 1.57% | — |
| 19 | N NRIX NURIX THERAPEUTICS INC | $16.6M | 684.3K | 1.57% | — |
| 20 | N NTRA NATERA INC | $16.6M | 61.0K | 1.56% | — |
| 21 | M MIRM MIRUM PHARMACEUTICALS INC | $16.3M | 139.2K | 1.54% | — |
| 22 | I INSM INSMED INC | $16.2M | 152.0K | 1.53% | — |
| 23 | T THC TENET HEALTHCARE CORP | $15.9M | 85.2K | 1.50% | — |
| 24 | T TMO THERMO FISHER SCIENTIFIC INC | $15.8M | 31.6K | 1.49% | — |
| 25 | C CNC CENTENE CORP DEL | $15.7M | 244.0K | 1.48% | — |
| 26 | A AXSM AXSOME THERAPEUTICS INC. | $15.4M | 63.0K | 1.46% | — |
| 27 | D DHR DANAHER CORPORATION | $15.3M | 80.3K | 1.44% | — |
| 28 | V VRTX VERTEX PHARMACEUTICALS INC | $15.2M | 30.7K | 1.44% | — |
| 29 | A AVR ANTERIS TECHNOLOGIES GLOBAL | $15.2M | 1.54M | 1.43% | — |
| 30 | N NBIX NEUROCRINE BIOSCIENCES INC | $14.5M | 85.8K | 1.37% | — |
| 31 | P PNTG PENNANT GROUP INC | $13.7M | 371.5K | 1.30% | — |
| 32 | I ISRG INTUITIVE SURGICAL INC | $13.7M | 34.5K | 1.29% | — |
| 33 | E ELV ELEVANCE HEALTH INC | $13.5M | 34.9K | 1.27% | — |
| 34 | L LIVN LIVANOVA PLC | $13.5M | 164.0K | 1.27% | — |
| 35 | C COR CENCORA INC | $13.2M | 46.8K | 1.25% | — |
| 36 | C CRL CHARLES RIV LABS INTL INC | $13M | 57.2K | 1.22% | — |
| 37 | I IDYA IDEAYA Biosciences Inc | $12.8M | 343.8K | 1.21% | — |
| 38 | M MCK MCKESSON CORP | $12.5M | 16.6K | 1.18% | — |
| 39 | S SNDX SYNDAX PHARMACEUTICALS INC | $12.2M | 560.3K | 1.16% | — |
| 40 | B BTSGU BRIGHTSPRING HEALTH SVCS INC | $11.6M | 165.9K | 1.09% | — |
| 41 | M MDT MEDTRONIC PLC | $11.3M | 145.0K | 1.07% | — |
| 42 | M MLYS MINERALYS THERAPEUTICS INC | $11.2M | 416.4K | 1.06% | — |
| 43 | O OSCR OSCAR HEALTH INC | $11.2M | 392.0K | 1.06% | — |
| 44 | R RPRX ROYALTY PHARMA PLC | $11M | 197.0K | 1.04% | — |
| 45 | D DXCM DEXCOM INC | $10.8M | 160.0K | 1.02% | — |
| 46 | A ALGN ALIGN TECHNOLOGY INC | $10.6M | 63.0K | 1.00% | — |
| 47 | S SYRE SPYRE THERAPEUTICS INC | $10.6M | 119.3K | 1.00% | — |
| 48 | R RLAY RELAY THERAPEUTICS INC | $10.6M | 566.0K | 1.00% | — |
| 49 | A ARWR ARROWHEAD PHARMACEUTICALS IN | $10.4M | 128.0K | 0.98% | — |
| 50 | A A AGILENT TECHNOLOGIES INC | $10M | 75.0K | 0.94% | — |